GT Biopharma Promotes COO to Top Post, Effective Immediately Post author:Sam Post published:February 14, 2018 Post category:BioPharma Mr. Cross has held the position of President and COO of GTBP since November 16, 2017. Source: BioSpace You Might Also Like AI Firm Exscientia Grabs EUR250 Million Small Molecules Pact With Sanofi May 8, 2017 FDA Slaps Clinical Hold on Solid Bioscience DMD Gene Therapy Program March 14, 2018 MabVax Therapeutics Board Of Directors Authorizes The Company To Explore Strategic Alternatives July 23, 2017
MabVax Therapeutics Board Of Directors Authorizes The Company To Explore Strategic Alternatives July 23, 2017